ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness

计划入组 50,000 人 · 首次发布于 2026 年 7 月 1 日

PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers

计划入组 121 人 · 首次发布于 2026 年 7 月 28 日

The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment

计划入组 90 人 · 首次发布于 2021 年 8 月 26 日

CASi-APOE

ApoE gene-silencing divalent siRNAs

apoE4 structure correctors (Numerate/J David Gladstone Institutes)

APO PLUS STATION CO., LTD.

Japan

Favorable Lifestyle Factors Reduce Dementia Risk Across Key Genetic Profiles, Japanese Study Finds

EMA Recommends Lecanemab for Early Alzheimer's, Limits Use to Specific Genetic Profiles

APOE-Stratified GWAS Uncovers New Alzheimer's Risk Loci and Supports A Priori APOE Stratification in AD Trials